Cargando...
Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
Immune checkpoint inhibitors (ICIs) are able to reactivate the immune system, thereby enhancing the anti‐tumor effects. However, over‐activated T cells may induce immune‐related adverse events (irAEs). Hematological irAEs are rarely reported which mainly represent monolineage cytopenia or pancytopen...
Gardado en:
| Publicado en: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049514/ https://ncbi.nlm.nih.gov/pubmed/32017466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13281 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|